Stock·NASDAQ·Technology
Analog Devices Inc. (ADI)
- Market cap
- $191.59B
- P/E
- 47.93
- Dividend yield
- 1.09%
- Street target
- $463.50median of 34 analysts
- 52-week range
- $223.47 $445.91
The short version
Where ADI stands today, in four lines, and what CleaRank Financial AI makes of it.
ADI at a glance
Analog Devices Inc. (ADI): Buy, 76/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($383.49 and $366.23).
- Earnings ADI beat estimates in 7 of its last 7 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $124.9M and made no open-market purchases over the last 18 months.
- Valuation P/E of 47.9 against 35.1 for the Technology sector: a premium to peers (+37%).
Figures as of October 16, 2026.
CleaRank Financial AI
Analog Devices Inc. (ADI) is trading at $395.375, above its 50-day and 200-day moving averages ($383.49 and $366.23), indicating a generally positive trend.
The company's revenue growth is projected to be strong, with current year estimates at +37.00% and next year at +20.00%. Wall Street consensus is predominantly positive, with 30 out of 34 analysts rating the stock as Buy or Strong Buy, and a median price target of $463.50 suggesting 17.2% upside. Despite the positive outlook, insider activity reveals significant selling pressure, with $124.9 million in total sales versus no reported purchases. This heavy sell signal warrants close monitoring, though it is important to note that the company's profit margin of 29.79% and operating margin of 39.50% remain strong, and its debt-to-equity ratio of 0.27 is well below the sector median of 0.27.
Only on CleaRank
Figures we compute ourselves from ADI's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $395.38 is 3.1% above the 50-day simple moving average of $383.49.Price above its 200-day average ›
The price is 8.0% above the 200-day simple moving average of $366.23.50-day average above the 200-day ›
The 50-day average ($383.49) is 4.7% above the 200-day average ($366.23), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 77% of its 52-week range, between $223.47 and $445.91.
ADI share price
Pick a period: each tab shows how far ADI has moved over it, to the last close.
Today's trading
Where ADI sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 47.93 is 36.6% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 14.09 is 85.4% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $4.1B on revenue of $13.9B, a net margin of 29.8%.Beat estimates in most recent reports ›
ADI beat the EPS estimate in 7 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.09%, or $4.29 a share a year.
Key statistics
The headline figures for ADI.
As of October 16, 2026, ADI trades at $395.38, with a market value of $191.59B, a P/E ratio of 47.93 and a dividend yield of 1.09%.
What the numbers say
CleaRank Financial AI's reading of ADI's valuation, growth and risks.
Analog Devices Inc. (ADI) trades at a P/E ratio of 47.93, which is higher than the sector median of 35.1, suggesting a premium valuation.
However, its Price-to-Sales ratio of 14.09 is also above the sector median of 7.6, but its strong profit margin of 29.79% and operating margin of 39.50% help justify this premium. The company's return on equity stands at 12.23%, slightly below the sector median of 13.4. With a debt-to-equity ratio of 0.27, which is in line with the sector median, the balance sheet appears healthy. The current valuation, while elevated compared to sector averages, is supported by strong profitability and projected growth.
ADI against the Technology sector
How ADI compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: ADI trades at a significant premium to sector peers (+37%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 6, 2025, ADI has gained 106.8% against a gain of 73.7% for XLK.
Performance against XLK
ADI and the Technology sector fund over the same days.
Revenue and earnings
How much ADI sells, and how much of it becomes profit.
Revenue growth: Revenue grew 16.9% in FY2025 to $11.0B, from $9.4B a year earlier.
Profit margin: The net margin was 20.6% in FY2025, up from 17.3% the year before.
Profitable: ADI earned $2.3B in FY2025.
Earnings reality check
Did ADI beat what analysts expected, and how did the stock react?
Earnings record: ADI beat the analyst estimate in 7 of the last 7 quarters.
Market reaction: The stock fell in the first session after 4 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 19, 2026after close | $3.34 | $3.45 | +3.29% | -0.81% | -0.39% |
| Feb 18, 2026after close | $2.31 | $2.46 | +6.49% | -0.31% | +4.17% |
| Nov 25, 2025after close | $2.23 | $2.26 | +1.35% | +2.34% | +10.40% |
| Aug 20, 2025after close | $1.95 | $2.05 | +5.13% | +0.85% | +4.34% |
| May 22, 2025after close | $1.70 | $1.85 | +8.82% | -0.69% | +0.97% |
| Feb 19, 2025after close | $1.54 | $1.63 | +5.84% | +0.89% | -3.28% |
| Nov 26, 2024after close | $1.64 | $1.67 | +1.83% | -0.86% | -0.34% |
As of October 16, 2026, ADI has beaten the analyst EPS estimate in 7 of its last 7 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on August 19, 2026, came in 3.29% above the estimate and the stock moved -0.81% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 56.4, in neutral territory.RSI above 50 ›
An RSI of 56.4 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of ADI
The score, the reasoning behind it, and what could move the price next.
Analog Devices Inc. (ADI) shows a neutral 14-day RSI of 56.4, suggesting neither overbought nor oversold conditions.
The stock is currently trading below its 20-day EMA of $400.18, which is acting as near-term resistance, but remains above its 50-day SMA of $383.49 and its 200-day SMA of $366.23, indicating a longer-term uptrend. Key support levels are found around the 50-day and 200-day SMAs, while the 20-day EMA presents an immediate resistance point. The MACD at 7.82 indicates positive momentum, though its proximity to zero suggests it is not strongly trending.
Strong Analyst Conviction and Price Targets ›
30 out of 34 analysts rate ADI as Buy or Strong Buy, with a median price target of $463.50, indicating significant Wall Street confidence in the stock's future performance.
Source: Wall Street SummaryStrong Revenue Growth Projections ›
Current year revenue growth is estimated at +37.00%, with next year projected at +20.00%, driven by demand in key semiconductor markets.
Source: Wall Street Revenue EstimatesConsistent Earnings Beats ›
Analog Devices Inc. has a track record of exceeding EPS estimates, most recently reporting a 3.29% beat on August 19, 2026.
Source: Earnings Reports
Heavy Insider Selling Pressure ›
Insiders have sold a total of $124.9 million in stock with no reported purchases, resulting in a heavy insider selling.
Source: Insider TransactionsPremium Valuation Relative to Sector ›
The stock's P/E ratio of 47.93 is significantly higher than the sector median of 35.1, posing a risk if growth expectations falter.
Source: Fundamental Analysis
- Monitor insider selling activity closely, as $124.9 million in dispositions have been reported, signaling heavy insider selling.
- The stock is trading below its 20-day EMA, suggesting potential near-term resistance around $400.18.
- Consider position sizing carefully given the premium valuation (P/E of 47.93) and the significant insider selling.
Technical indicators
Momentum and trend for ADI, from its daily closes.
As of October 16, 2026, with ADI at $395.38, its 14-day RSI is 56.4 (neutral territory), its 50-day simple moving average is $383.49 and its 200-day is $366.23.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What ADI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, ADI's 1-year correlation of daily returns is +0.70 with S&P 500 (SPY), +0.71 with Nasdaq 100 (QQQ), +0.19 with Bitcoin (BTC) and +0.17 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
30 of 34 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $463.50 is 17.2% above the price.More buy ratings than three months ago ›
30 of 34 rate it a buy now, against 27 of 33 three months ago.
ADI Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 8, 2026 | TD Cowen | Reiterates | Buy |
| Aug 24, 2026 | Baird | Maintains | Outperform |
| Aug 21, 2026 | BMO Capital | Initiates | Outperform |
| Aug 20, 2026 | JP Morgan | Maintains | Overweight |
| Aug 20, 2026 | Morgan Stanley | Maintains | Overweight |
| Aug 20, 2026 | Bernstein | Upgrade | Outperform |
As of October 16, 2026, 34 Wall Street analysts cover ADI: 30 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $365.00 to $675.00, with a median of $463.50, 17.2% above the price of $395.38.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ADI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from ADI's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ADI tends to move, against the market and on its own.
The long record
ADI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.92% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 29.5%, from July 2024 to April 2025, regained by June 2025.Most 1-year holds ended higher ›
88% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $78,689, against $42,525 in the S&P 500 (SPY).
ADI Drawdowns & Recovery
As of October 16, 2026, ADI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -29.5% (July 2024 to April 2025); it regained that peak by June 2025, 2 months after the low, and 88% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ADI in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: ADI beat the S&P 500 over this period: $78,689 against $42,525.
A $10,000 investment in ADI in October 2016 would be worth about $78,689 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ADI, and which have not.
Strongest month, November: an average of +8.80%, up in 8 of 10 years.
Weakest month, March: an average of -3.40%, up in 3 of 10 years.
This month, October: has averaged -2.42%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, ADI's strongest calendar month has been November (average +8.80%, up in 8 of 10 years) and its weakest March (average -3.40%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ADI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ADI today could grow to about $26,777 by 2036 in the base case, with a 90th-percentile outcome near $103,038 and a 10th-percentile outcome around $6,959. The simulation models price only; at today's 1.09% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
ADI Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $586 for ADI by 2030 in the base case, from $395 today (1.5x over 4 years). The 10th-percentile path ends near $250. These are outcomes of a Monte Carlo simulation run on ADI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $285 | $436 | $668 | |
| 2028 | $264 | $481 | $880 | |
| 2029 | $254 | $531 | $1,111 | |
| 2030 | $250 | $586 | $1,375 | |
| 2031 | $250 | $647 | $1,678 |
Method: a lognormal simulation of ADI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
ADI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought ADI shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, ADI insiders reported 52 open-market sales worth $124.9M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Raymond S Stata
Director
|
Sell | 2.8K | $1.2M |
| Oct 6, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 1.5K | $631.6K |
| Oct 2, 2026 | Vivek Jain
Chief Operating Officer
|
Sell | 2.0K | $834.0K |
| Oct 2, 2026 | Katsufumi Nakamura
Officer
|
Sell | 1.2K | $498.0K |
| Oct 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $4.0M |
| Oct 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Sep 22, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 1.5K | $573.3K |
| Sep 18, 2026 | Vincent T Roche
Chief Executive Officer
|
Grant | 19.2K | - |
| Sep 9, 2026 | Raymond S Stata
Director
|
Sell | 2.8K | $1.0M |
| Sep 8, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 1.5K | $545.5K |
| Sep 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.6M |
| Sep 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Aug 27, 2026 | Karen M. Golz
Director
|
Sell | 1.0K | $374.5K |
| Aug 26, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Sell | 2.7K | $1.0M |
| Aug 5, 2026 | Raymond S Stata
Director
|
Sell | 2.8K | $1.1M |
| Aug 3, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.6M |
| Aug 3, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Jul 13, 2026 | Karen M. Golz
Director
|
Sell | 1.0K | $389.8K |
| Jul 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.9M |
| Jul 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| Jun 12, 2026 | Karen M. Golz
Director
|
Sell | 1.0K | $412.0K |
| Jun 9, 2026 | Raymond S Stata
Director
|
Sell | 1.4K | $574.0K |
| Jun 2, 2026 | Martin Cotter
Officer
|
Sell | 17.6K | $7.4M |
| Jun 2, 2026 | Martin Cotter
Officer
|
Option | 17.6K | $1.5M |
| Jun 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $4.0M |
| Jun 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $1.1M |
| May 26, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 60.0K | $24.4M |
| May 26, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 60.0K | $8.6M |
| May 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $4.0M |
| May 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Apr 7, 2026 | Martin Cotter
Officer
|
Grant | 5.8K | - |
| Apr 7, 2026 | Vivek Jain
Officer
|
Grant | 6.7K | - |
| Apr 7, 2026 | Katsufumi Nakamura
Officer
|
Grant | 4.1K | - |
| Apr 7, 2026 | Richard C. Puccio Jr.
Chief Financial Officer
|
Grant | 6.5K | - |
| Apr 7, 2026 | Vincent T Roche
Chief Executive Officer
|
Grant | 19.7K | - |
| Apr 7, 2026 | Michael Sondel
Officer
|
Grant | 1.3K | - |
| Apr 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.2M |
| Apr 1, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Mar 18, 2026 | Martin Cotter
Officer
|
Grant | 8.0K | - |
| Mar 18, 2026 | Vivek Jain
Officer
|
Grant | 12.6K | - |
| Mar 18, 2026 | Katsufumi Nakamura
Officer
|
Grant | 399 | - |
| Mar 18, 2026 | Vincent T Roche
Chief Executive Officer
|
Grant | 55.9K | - |
| Mar 18, 2026 | Michael Sondel
Officer
|
Grant | 958 | - |
| Mar 11, 2026 | Raymond S Stata
Director
|
Sell | 6.3K | $2.0M |
| Mar 11, 2026 | Andre Andonian
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Edward H Frank
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Karen M. Golz
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Peter B Henry
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Stephen M Jennings
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Mercedes Johnson
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Yoky Matsuoka
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Raymond S Stata
Director
|
Grant | 747 | - |
| Mar 11, 2026 | Andrea F Wainer
Director
|
Grant | 747 | - |
| Mar 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.5M |
| Mar 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Feb 25, 2026 | Michael Sondel
Officer
|
Sell | 4.2K | $1.5M |
| Feb 17, 2026 | Yoky Matsuoka
Director
|
Grant | 97 | - |
| Feb 5, 2026 | Raymond S Stata
Director
|
Sell | 6.3K | $2.0M |
| Feb 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $3.1M |
| Feb 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Jan 14, 2026 | Raymond S Stata
Director
|
Sell | 6.3K | $1.9M |
| Jan 9, 2026 | Katsufumi Nakamura
Officer
|
Sell | 500 | $150.7K |
| Jan 7, 2026 | Katsufumi Nakamura
Officer
|
Sell | 500 | $144.6K |
| Jan 5, 2026 | Martin Cotter
Officer
|
Sell | 10.0K | $2.8M |
| Jan 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.8M |
| Jan 2, 2026 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Dec 17, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.7M |
| Dec 17, 2025 | Martin Cotter
Officer
|
Sell | 5.0K | $1.4M |
| Dec 12, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.8M |
| Dec 12, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Dec 10, 2025 | Michael Sondel
Officer
|
Sell | 8.2K | $2.3M |
| Dec 10, 2025 | Michael Sondel
Officer
|
Option | 8.2K | $795.0K |
| Dec 9, 2025 | Martin Cotter
Officer
|
Grant | 1.6K | - |
| Dec 9, 2025 | Vivek Jain
Officer
|
Grant | 2.5K | - |
| Dec 9, 2025 | Katsufumi Nakamura
Officer
|
Grant | 135 | - |
| Dec 9, 2025 | Vincent T Roche
Chief Executive Officer
|
Grant | 10.8K | - |
| Dec 9, 2025 | Michael Sondel
Officer
|
Grant | 203 | - |
| Dec 4, 2025 | Vincent T Roche
Chief Executive Officer
|
Grant | 18.8K | - |
| Dec 1, 2025 | Vivek Jain
Officer
|
Sell | 5.9K | $1.6M |
| Nov 5, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.5M |
| Nov 3, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.3M |
| Nov 3, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Oct 7, 2025 | Vincent T Roche
Chief Executive Officer
|
Grant | 11.3K | - |
| Oct 6, 2025 | Edward H Frank
Director
|
Sell | 1.0K | $242.7K |
| Oct 2, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.5M |
| Oct 1, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.4M |
| Oct 1, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Sep 18, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.6M |
| Sep 5, 2025 | Martin Cotter
Officer
|
Sell | 12.5K | $3.1M |
| Sep 2, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.5M |
| Sep 2, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
| Aug 27, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 20.0K | $5.1M |
| Aug 21, 2025 | Katsufumi Nakamura
Officer
|
Sell | 2.5K | $617.6K |
| Aug 21, 2025 | Katsufumi Nakamura
Officer
|
Option | 2.5K | $226.9K |
| Aug 6, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.4M |
| Jul 17, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.5M |
| Jun 12, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.5M |
| May 7, 2025 | Raymond S Stata
Director
|
Sell | 6.3K | $1.2M |
| May 1, 2025 | Vincent T Roche
Chief Executive Officer
|
Sell | 10.0K | $2.0M |
| May 1, 2025 | Vincent T Roche
Chief Executive Officer
|
Option | 10.0K | $944.1K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.